Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,205 | -6,768 | -2,834 | -11,850 | -9,121 |
| Depreciation Amortization | 1 | 1 | 0 | 1 | 1 |
| Accounts payable and accrued liabilities | -154 | -95 | -328 | 569 | 400 |
| Other Working Capital | 915 | 606 | -146 | -112 | -416 |
| Other Operating Activity | 958 | 1,257 | 579 | 147 | 139 |
| Operating Cash Flow | $-8,485 | $-5,000 | $-2,730 | $-11,245 | $-8,997 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -3 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-3 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,619 | 10,759 | 4,439 | 7,763 | 7,214 |
| Other Financing Activity | -17 | -13 | -3 | -30 | -28 |
| Financing Cash Flow | $13,602 | $10,746 | $4,436 | $7,733 | $7,186 |
| Beginning Cash Position | 1,191 | 1,191 | 1,191 | 4,706 | 4,706 |
| End Cash Position | 6,308 | 6,937 | 2,897 | 1,191 | 2,892 |
| Net Cash Flow | $5,117 | $5,745 | $1,706 | $-3,515 | $-1,815 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,485 | -5,000 | -2,730 | -11,245 | -8,997 |
| Capital Expenditure | N/A | N/A | N/A | -3 | N/A |
| Free Cash Flow | -8,485 | -5,000 | -2,730 | -11,248 | -8,997 |